Clinical Laserthermia Systems AB – Strategy, SWOT and Corporate Finance Report

Clinical Laserthermia Systems AB – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a precise and safe treatment. It also comprises a laser applicator with introducer that is used for positioning of the fiber, depending on the tumor size. TRANBERG is developed for immune stimulating interstitial thermotherapy (imILT). CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its products to hospitals and clinics. CLS is headquartered Lund, Sweden.

Scope

Detailed information on Clinical Laserthermia Systems AB required for business and competitor intelligence needs

A study of the major internal and external factors affecting Clinical Laserthermia Systems AB in the form of a SWOT analysis

An in-depth view of the business model of Clinical Laserthermia Systems AB including a breakdown and examination of key business segments

News about Clinical Laserthermia Systems AB, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Clinical Laserthermia Systems AB and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Clinical Laserthermia Systems AB as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Clinical Laserthermia Systems ABs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

SpectraCure AB

Seno Medical Instruments Inc

OraSolv AB

Micropos Medical AB

Elekta AB

Dignitana AB

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Clinical Laserthermia Systems AB - Key Facts 5

Clinical Laserthermia Systems AB - Key Employees 6

Clinical Laserthermia Systems AB - Key Employee Biographies 7

Clinical Laserthermia Systems AB - Major Products and Services 8

Clinical Laserthermia Systems AB - History 9

Clinical Laserthermia Systems AB - Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2 Company Analysis 12

Company Overview 12

Clinical Laserthermia Systems AB - Business Description 13

Clinical Laserthermia Systems AB - SWOT Analysis 14

SWOT Analysis - Overview 14

Clinical Laserthermia Systems AB - Strengths 14

Clinical Laserthermia Systems AB - Weaknesses 15

Clinical Laserthermia Systems AB - Opportunities 16

Clinical Laserthermia Systems AB - Threats 17

Clinical Laserthermia Systems AB - Key Competitors 18

Section 3 Company Financial Ratios 19

Financial Ratios - Capital Market Ratios 19

Financial Ratios - Annual Ratios 20

Performance Chart 22

Financial Performance 22

Financial Ratios - Interim Ratios 23

Financial Ratios - Ratio Charts 24

Section 4 Company’s Lifesciences Financial Deals and Alliances 25

Clinical Laserthermia Systems AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 25

Clinical Laserthermia Systems AB, Medical Equipment, Deals By Type, 2012 to YTD 2018 26

Clinical Laserthermia Systems AB, Recent Deals Summary 27

Section 5 Company’s Recent Developments 28

Jan 02, 2018: CLS single use accessories evaluated by Laser Prostate Centers of America 28

Nov 28, 2017: CLS expands the product portfolio with new diffusing fiber for optimal thermal treatment of larger cancer tumors 29

Nov 16, 2017: CLS receives additional order from University of Texas Medical Branch in the US 30

Oct 19, 2017: CLS signs supplier agreement with University of Texas Medical Branch and receives the first order 31

May 11, 2017: CLS products for MR-guided laser ablation evaluated at University of Texas Medical Branch 32

Mar 10, 2017: CLS secures commercial access to important fiber technology. Purchases parts of the German laser technology company Laser- und Medizin-Technologie 33

Section 6 Appendix 34

Methodology 34

Ratio Definitions 34

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Tables

List of Tables

Clinical Laserthermia Systems AB, Key Facts 5

Clinical Laserthermia Systems AB, Key Employees 6

Clinical Laserthermia Systems AB, Key Employee Biographies 7

Clinical Laserthermia Systems AB, Major Products and Services 8

Clinical Laserthermia Systems AB, History 9

Clinical Laserthermia Systems AB, Subsidiaries 11

Clinical Laserthermia Systems AB, Key Competitors 18

Clinical Laserthermia Systems AB, Ratios based on current share price 19

Clinical Laserthermia Systems AB, Annual Ratios 20

Clinical Laserthermia Systems AB, Annual Ratios (Cont…1) 21

Clinical Laserthermia Systems AB, Interim Ratios 23

Clinical Laserthermia Systems AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 25

Clinical Laserthermia Systems AB, Medical Equipment, Deals By Type, 2012 to YTD 2018 26

Clinical Laserthermia Systems AB, Recent Deals Summary 27

Currency Codes 34

Capital Market Ratios 34

Equity Ratios 35

Profitability Ratios 35

Cost Ratios 36

Liquidity Ratios 36

Leverage Ratios 37

Efficiency Ratios 37

List of Figures

List of Figures

Clinical Laserthermia Systems AB, Performance Chart (2013 – 2017) 22

Clinical Laserthermia Systems AB, Ratio Charts 24

Clinical Laserthermia Systems AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 25

Clinical Laserthermia Systems AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 26

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports